Efficacy & Safety of STG320 Sublingual Tablets of HDM Allergen Extracts in Adults and Adolescents With HDM-associated AR

Completed · Phase 3 · Has a placebo group

Conditions studied: Rhinitis, Allergic, Perennial, House Dust Mite Allergy

In brief

The objective of this study was to assess the efficacy and safety of 12 months of treatment with 300 IR of STG320 sublingual tablets compared with placebo in adults and adolescents with HDM-associated allergic rhinitis.

Key facts

Study ID

NCT02443805

Run by

Stallergenes Greer

People needed

1607

Starts

2015-09-29

Expected to finish

2018-06-25

Last updated by the study team

2019-10-14

Who can join

Age: 12 and older, up to 65. Sex: any. Healthy volunteers: not accepted.

Where it is running

• University of South of Florida — Tampa, Florida, United States
• CHU Arnaud de Villeneuve — Montpellier, France

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.